Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Gus Monsanto Gus Monsanto Gus Monsanto is the stage name of Gustavo Monsanto (born 5. November 1974 in Petrópolis, Rio de Janeiro state, Brazil) is the former lead singer of the French progressive metal band Adagio, and former lead singer of Finnish band Revolution Renaissance formed by Timo Tolkki after he left Stratovarius. He is the brother of journalist Eduardo Monsanto of ESPN Brazil. In 2009 he released an album as frontman of the band The Lightseekers. Gus Monsanto is the new singer of German metal band Human Fortress and he is singing on the new album which was released November 9.